Abstract Assembly of complex vascular networks occurs in numerous biological systems through morphogenetic processes such as vasculogenesis, angiogenesis and vascular remodeling. Pluripotent stem cells such as embryonic stem (ES) and induced pluripotent stem (iPS) cells can differentiate into any cell type, including endothelial cells (ECs), and have been extensively used as in vitro models to analyze molecular mechanisms underlying EC generation and differentiation. The emergence of these promising new approaches suggests that ECs could be used in clinical therapy. Much evidence suggests that ES/iPS cell differentiation into ECs in vitro mimics the in vivo vascular morphogenic process. Through sequential steps of maturation, ECs derived from ES/iPS cells can be further differentiated into arterial, venous, capillary and lymphatic ECs, as well as smooth muscle cells. Here, we review EC development from ES/iPS cells with special attention to molecular pathways functioning in EC specification.
Introduction
Diverse pathways give rise to the vertebrate circulatory system, which forms early in embryogenesis. Vascular ECs initially differentiate from mesoderm-derived angioblasts, which form a primitive vascular plexus at or near their sites of origin during the onset of vascularization (vasculogenesis) [1] . Arterially-fated angioblasts adjacent to the endoderm form the first artery (the dorsal aorta) ventrally, whereas venous-fated angioblasts migrate dorsally and form the first vein (the cardinal vein) adjacent to the neural tube [2] . The angioblast develops to ultimately form arterial and venous ECs, depending on activation of specific molecular pathways and expression of other factors. Through a sequential maturation process, arterial and venous ECs become functionally specified, giving rise to functional blood vessels such as arteries, veins and capillaries [3] . Arteries transport oxygen-rich blood to all tissues, and veins bring oxygendepleted blood back to the heart. Arteries are thicker-walled vessels surrounded by multiple layers of vascular smooth muscle cells. Veins are thinner-walled vessels with little smooth muscle and exhibit valves to prevent backflow of blood ( Fig. 1 ).
Key Regulators of the Vascular Network
Two mechanisms are central to formation of the vascular network: vasculogenesis and angiogenesis [1] . Vasculogenesis gives rise to anatomically and physiologically distinct vessels such as arteries and veins, whereas angiogenesis is a process in which new capillaries form from the parent vessel [1, 4] . Arterial and venous ECs have been molecularly defined and are specified embryonically prior to establishment of the circulation or tubulogenesis (the formation of a branching structure from specific ducts) [3] . Arterial ECs are characterized by expression of Ephrin-B2 ligand, which binds to the EphB4 receptor expressed on venous ECs to regulate arterial-venous EC specification before the circulatory system is established [5, 6] . In addition, as they form primitive blood vessels exhibiting lumens, venous ECs further differentiate into lymphatic ECs in the presence of specific stimuli mentioned in this review.
Molecular pathways underlying EC lineage commitment and differentiation into mature cell types have been widely studied using animal models and ES/iPS cells [7] [8] [9] [10] ; however, how these complex signaling pathways and downstream molecules act together in arterial-venous EC specification remains to be fully understood. Multistep regulatory systems implicated in arterial, venous and lymphatic EC specification are summarized in Fig. 2 and reviewed below.
Arterial EC Specification
The Sonic Hedgehog (SHH) Signaling Pathway SHH is the mammalian homologue of the Drosophila hedgehog protein. In flies, hedgehog is the ligand activating a pathway composed of the Patched receptor, the signal transducer Smoothened and a cytoplasmic component, Cubitus interruptus (also known as GLI3 protein in mammals), which is tethered to the Smoothened carboxyl tail and plays an indispensable role in governing cell fate and embryonic patterning [11, 12] . Patched forms a complex with the seven-pass membrane protein, Smoothened, maintaining it in an inactive form. In flies, Hedgehog-bound Patched receptor dissociates from Smoothened, allowing activated Smoothened to disengage from Cubitus interruptus, which then enters the nucleus to activate downstream targets [13] . Wild-type zebrafish embryos exposed to cyclopamine, a hedgehog inhibitor, or treated with vegf anti-sense morpholinos show down-regulation of artery-specific markers such as Ephrin-B2, while microinjection of vegf mRNA into zebrafish embryos lacking Shh activity rescues arterial EC specification [8] . These observations suggest that the SHH pathway acts upstream of VEGF in arterial EC specification in zebrafish [8] . However, in zebrafish embryos in which Notch signaling is blocked, injection of vegf mRNA fails to induce expression of arterial markers, such as Ephrin-B2 and notch5 (also known as notch3), suggesting that VEGF acts downstream of SHH but upstream of Notch signaling [14] .
Vascular Endothelial Growth Factor (VEGF)
VEGF family proteins stimulate vasculogenesis and angiogenesis and through EC proliferation, survival and migration. In mammals, the family is composed of VEGF-A, VEGF-B, VEGF-C, VEGF-D and placental growth factor (PIGF) [15] . VEGF-A and its receptor VEGFR-2 and coreceptor neuropilin-1 (NP-1) are involved in arterial EC specification [16] . VEGF-A binding to VEGFR-2 stimulates receptor auto-phosphorylation and rapid recruitment of SH2-containing intracellular signaling molecules such as phosphoinositide 3-kinase (PI3Ks), mitogen-activated protein kinase (MAPK)/ERK, Src family tyrosine kinases, Ras, phospholipase Cγ1, Shc, Grb2 and Nck adaptor molecules [17] . In humans and mice, VEGF-A exists in at least three isoforms: VEGF 120 , VEGF 164 and VEGF 188 in mice, and VEGF 121 , VEGF 165 and VEGF 189 in humans [18, 19] . Each reportedly functions uniquely in vascular development, as they differ in receptor binding, matrix association and angiogenic activity [20] . Transgenic mice that selectively express single isoforms of VEGF 120 and VEGF 164 show normal arterial development in retina, but those expressing an isoform of VEGF 188 exhibit normal venular outgrowth with impaired arterial development [21] , suggesting that VEGF 120 and VEGF 164 drive differentiation toward arterial EC specification, whereas VEGF 188 governs venous EC specification [21] . Loss of VEGF 164 in mice downregulates Ephrin-B2 expression, suggesting that VEGF 164 accelerates arterial EC specification [21] . 
Notch Signaling
Notch signaling is highly conserved among species, and it regulates the fate of numerous embryogenic tissues [22] . There are 4 types of Notch receptors (Notch1, 2, 3 and 4) and several ligands of the Delta-like (Dll) and Jagged families. A Notch effector, HERP (HES-related repressor protein; also called Hey/Hesr/HRT/CHF/gridlock) plays critical roles in promoting arterial EC specification [23] [24] [25] . Notch receptors 1 and 4 and their ligand delta-like 4 (Dll4) are specifically detected in Ephrin-B2-positive ECs of the dorsal aorta and umbilical artery [26] . Dll4 was originally identified as a ligand for Notch1 and Notch4 during vascular development [27] . In fact, although Notch1 and Dll4 reportedly function in arterial EC specification, Notch4 does not [27, 28] . In addition, Dll4-ablated mouse embryos show a reduction in the diameter of the dorsal aorta, and arterial ECs exhibit an irregular morphology, suggesting that Dll4 functions in arterial EC specification [2] .
In vitro analysis indicates that VEGF-A induces Notch1 and Dll4 expression in human arterial ECs through the PI3Ks/Akt pathway [28] . By contrast, in zebrafish embryos, chemical inhibition of the PI3Ks/Akt pathway by GS4898 induces arterial EC specification by activating MAPK pathways [29] . These opposing outcomes are likely due to the difference of species. Furthermore, in mouse pulmonary ECs, Foxc1 and Foxc2 up-regulate expression of Dll4 and Hey2 (a HERP homologue) through binding to their promoter regions, suggesting that Foxc induces arterial EC specification through Notch signaling [30] . Hey2-ablated mice die by postnatal day 10 due to severe cardiac defects but show no obvious abnormality in ECs, while Hey1-ablated mice develop normally [23, [31] [32] [33] . However, Hey1/2 double knockout mutants die by embryonic day (E) 9.5 due to failure of vascular remodeling and exhibit low expression of arterial EC markers such as Ephrin-B2, NP-1 and CD44 [23] . Over-expression of Hif1a (hypoxia-inducible factor 1-alpha) in T17b EC progenitor lines up-regulates Dll4 and Hey2 and down-regulates COUP-TFII (a regulator of venous EC specification), implying that hypoxia determines arterial EC specification [34] .
Venous EC Specification

COUP-TFII
The orphan nuclear receptor, COUP-TFII (chicken ovalbumin upstream-transcription factor II; official gene symbol; Nr2f2) is detected in the cardinal vein but not in the dorsal aorta in the mouse embryo by immunohistochemistry and genetic approach using COUP-TFII/lacZ 'knock-in' mouse model [35, 36] . COUP-TFII governs venous EC specification by suppressing expression of arterial specific genes, such as NP-1 and Notch1 [35] . Endothelial-specific COUP-TFII knockout mice (Tie2-Cre/+; COUP-TFII flox/flox mice) exhibit thin and well-dilated vessels and die of hemorrhage by E12 [35] . In the veins of these mutant mice, expression of arterial EC markers such as NP-1, Jagged1, Notch 1, HESR-1 (Hey1) and Ephrin-B2 appear in venous ECs [35] . Immunohistochemical staining of expression of the venous EC marker EphB4 indicates reduced expression, suggesting that COUP-TFII acts at upstream of NP-1 to suppress Notch signaling in venous EC specification [35] . In addition, endothelial cell-specific overexpression of COUP-TFII in transgenic mouse embryos impairs angiogenesis in the yolk sac and down-regulates . c The transcription factor Sox18 cooperates with COUP-TFII to activate expression of the homeobox transcription factor Prox1. Prox1 expression becomes independent of external stimuli and regulates its own expression to maintain lymphatic EC identity expression of Jagged1 as detected by immunohistochemical staining in aortic ECs, promoting embryonic lethality by E10-E11.5 [35] . These phenotypes resemble those displayed by NP-1 and Notch1 knockout embryos, suggesting that COUP-TFII functions upstream of NP-1 and Notch1 to regulate arterial-venous EC specification.
Capillary EC Formation
Capillaries, which are the smallest blood vessels, connect arteries and veins. Although EC studies relevant to capillaries have emerged in the past decade [37] , how capillary ECs are specified remains elusive. Capillaries form a large network of capillary beds (collections of capillaries) supplying oxygen and nutrients to tissue [38] . The three structurally different types of capillaries include continuous capillaries, fenestrated capillaries and sinusoidal capillaries (sinusoids) ( Table 1 ) [39] . Among them, sinusoids exhibit a discontinuous basal lamina enabling formation of open pores, but lack a diaphragm [40] . Such open pores increase capillary permeability, allowing transport of small molecules [40] . Liver sinusoidal endothelial cells line liver sinusoids and allow medium-sized proteins such as albumin to be transported into the circulation [41] . Liver sinusoidal endothelial cells also exclude large circulating particles such as blood cells, chylomicrons and platelets [41] . In addition, liver sinusoidal endothelial cells reportedly clear the macromolecule hyaluronan from the circulatory system and critically regulate liver regeneration by secreting angiogenic factors such as wingless-related MMTV integration site 2 (Wnt2) and hepatocyte growth factor (HGF), which promote hepatocyte proliferation [42] . The lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), a member of the scavenger receptor family, is expressed on embryonic blood vessels [43] and liver sinusoidal endothelial cells surface (Fig. 3 ). LYVE-1 is not expressed on other hepatic cells or on the conventional endothelium [44] . Cysteine-rich transmembrane BMP regulator 1 (CRIM1) mRNA and protein are expressed in human capillary ECs that also express platelet endothelial cell-adhesion molecule (PECAM)-1 (also known as CD31) [45] . CRIM1 knockdown with antisense oligonucleotides in cultured human umbilical vein ECs impairs capillary formation in Matrigel assay (a method for quantifying angiogenesis), implying that CRIM1 functions in capillary formation in vivo [45] . In addition, capillary formation, particularly sprouting, is induced in human umbilical vein EC spheroids in collagen gels following bone morphogenetic protein (BMP)-4 treatment, via both Smad and Extracellular-Signal Regulated Kinase (ERK) signaling [46] . Blocking ERK signaling with a MEK inhibitor impairs capillary formation in vitro, suggesting that the ERK pathway is essential for capillary formation through BMP signaling.
Lymphatic EC Specification
The specification of lymphatic ECs occurs after arterialvenous EC specification [47] . The lymphatic network forms a second vascular system, which complements the vascular network by modulating tissue fluid balance, allowing interstitial protein transport, and initiating the immune response [48] . The network is composed of a highly branched network of lymphatic capillaries and vessels [48] . Lymphatic capillaries are blind-ended vessels comprised of a single, nonfenestrated EC layer, whereas lymphatic vessels are lined with ECs and exhibit a thin wall with valves to transport fluid to the lymph node [48, 49] . After venous EC specification, a subpopulation of venous ECs is able to acquire a lymphatic EC fate by expressing the transcription factors Sox18 (SRY (sex determining region Y)-box 18) and Prox1 (Prosperorelated homeobox 1, a homeobox transcription factor) [50] .
SOX-18 is first expressed in ECs lining the dorsolateral sector of the cardinal vein at E9 in mice, approximately 1.5 day prior to the onset of PROX-1 expression [51] . Lymphatic ECs expressing Prox1 reportedly sprout from intersomitic vessels as well as the cardinal vein to form lymph sacs [52] . In Vegfc-deficient embryos, lymphatic ECs failed to sprout, as observed by immunohistochemistry of the jugular region using lymphatic EC markers such as VEGFR-3, LYVE-1 and podoplanin [53] . In addition, VEGF-C (a VEGFR-3 ligand) rescues lymphatic EC sprouting in whole-mount explants of this mutant [53] . In addition to SOX18, COUP-TFII is required to activate PROX1 through direct binding to the Prox1 promoter region in a study using cultured human lymphatic ECs [54] . Proximity ligation assays indicate that endogenous PROX1 and COUP-TFII interact in the nuclei of human dermal lymphatic ECs [55] . PROX1 is co-expressed with COUP-TFII in mouse lymphatic ECs at E11.5 [55] . When COUP-TFII is over-expressed in human dermal lymphatic ECs, PROX1, CCNE1 and VEGFR3 mRNAs are downregulated [55] . Taken together, Sox18 and COUP-TFII are required for Prox1 up-regulation in venous ECs, and Vegfc is required for lymphatic EC sprouting after lymphatic EC specification by Prox1.
In Vitro Differentiation of ECs from ES and iPS Cells
ES and iPS cells are of great interest for their potential use in vascular EC differentiation for purposes of regenerative medicine [56] . Pluripotent human ES cells develop into various cell types found in the adult human body, including cells that form the human vasculature [57, 58] . Like ES cells, iPS cells can be reprogrammed from adult cells and differentiated into the three germ layers. Recently, iPS cell generation has become technically simpler, enabling establishment of patient-specific pluripotent stem cells with fewer ethical concerns [59] . However, investigators have devised different methods to differentiate ECs from ES and iPS cells.
For better understanding of EC differentiation from ES/iPS cells, we review these methods below.
EC Differentiation from Embryoid Bodies (EBs)
Induction of ECs Through EB Formation from Mouse ES Cells
Conventional methods to form EBs include liquid suspension culture in petri-dishes, methylcellulose semisolid culture, or hanging drop culture [60] . Alternatively, ES cells can also be plated in semisolid 1 % methylcellulose-containing medium, on mouse embryonic fibroblasts (MEFs), or in Matrigel to form EBs [61, 62] . ES cell lines established from the inner cell mass of the mouse blastocyst maintain pluripotency when cultured in the presence leukemia inhibitory factor (LIF) [63] . EBs are three-dimensional (3D) multicellular aggregates formed spontaneously from ES cells in vitro in the absence of LIF. After 3-8 days of suspension culture, EBs form all three germ layers, like cells that found in the developing embryo and yolk sac [64] . After 8-10 days, approximately 50 % of EBs begin to form a large cystic structure resembling the visceral yolk sac of the post-implantation embryo [64] . Capillary-like structures reportedly form on the surface of ESderived cystic EBs, suggesting that during in vitro differentiation these cells undergo vasculogenesis and angiogenesis [10] . Alternatively, EBs can be formed in 3 days of ES cells cultured using the hanging drop method and then transferred to gelatin-coated wells of Chamber slides to allow attachment [65] . To promote EC differentiation from EBs, EBs are maintained in endothelial growth medium-2 (EGM-2), which contains VEGF-A and basic fibroblast growth factor (bFGF), and 5 % fetal bovine serum [65, 66] . Using this method, ES cells differentiate into ECs after 10 days of culture, as detected by the presence of mRNA and protein of EC markers such as FLK-1, CD31 and VE-cadherin [65] . When ECs are cultured for 5 more days in Matrigel, they form capillary-like structures [65] . However, capillary-like structures are not formed when gelatin-coated dishes are used [65] .
To induce EB formation, ES cells are trypsinized and plated in semisolid 1 % methylcellulose-containing medium (at day 0) [62] . EBs are cultured for up to 11 days in the presence of recombinant VEGF, erythropoietin (EPO) and bFGF to induce ECs [62] . The composition of growth factors in the culture medium determines the number and size of EBs and whether capillary-like structures appear in EBs [67] . Flk-1 expression, an early marker of EC precursors, is upregulated by day 3 of EB development [62, 68] . Expression of genes such as CD31 and Tie-2, both are the markers of ECs and hematopoietic progenitor cells is detected on day 4 [62] . Early co-expression of three genes (Flk-1, Pecam-1 and Tie-2) reflects commitment towards an endothelial lineage [62] . On day 5, Cdh5 and Tie-1 expression begins in the culture system. Immunohistochemical analysis shows growth factor receptors (FLK-1 and TIE-2), adhesion molecules (CD31 and VE-cadherin) and endothelial specific antigens (MECA-32 and MEC-14) are expressed from day 5 to day 11 [62] .
Induction of ECs Through EB Formation from Human ES Cells
Human ES cells also differentiate into ECs through EB formation. Human ES cells (H9 clone) are maintained in an undifferentiated state in the presence of LIF and bFGF [69] . To form EBs, ES cells are dissociated and then grown in the absence of LIF and bFGF on petri dishes for a maximum of 13-15 days to allow cell aggregation [70, 71] . Levels of ECspecific mRNAs such as CD31, VE-cadherin and CD34 increase during the EB differentiation period [71, 72] . To evaluate whether EC surface markers are expressed in this process, CD31-expressing cells were isolated by flow cytometry and re-cultured on a 1 % gelatin-coated plates in EGM-2 medium for several passages [73] . Several adhesion molecules were detected at adherens junctions, including N-cadherin and VEcadherin, and cells spontaneously formed capillary-like structures when maintained in Matrigel for several days [73] . On the other hand, capillaries can also be formed by seeding 8 to 9 day-old EBs in Matrigel supplemented with TGF-β1, activin-A, insulin-like growth factor and retinoic acid [70] .
In another study, human ES cells were cultured in vitro for 2 weeks and then transplanted into severe combined immunodeficient (SCID) mice, where they formed capillaries along with the mouse vasculature [73] . Alternatively, lentiviral transduction of human ES cells with a fragment containing the genomic locus of the human EC-specific gene VEcadherin (CDH5) from a bacterial artificial chromosome favors EC formation [74] . To induce EB formation using these cells, cells transduced with this sequence upstream of a GFP marker (hVPr-GFP) were grown to confluence on Matrigel in the absence of FGF-2 [74] . On day 4, EBs were replated on Matrigel-coated plates and supplemented with VEGF-A. By day 8, hVPr-GFP+ cells not only expressed EC-specific markers such as VE-cadherin, CD31, D34 and FLK-1 but also formed capillary-like structures. These cells were negative for α-SMA (a smooth muscle marker) and CD45 (a hematopoietic cell marker) [74] .
EC Differentiation from ES Cells Cultured on Type IV Collagen-Coated Dishes or OP9 Feeder Layers
Induction of ECs from Mouse ES Cells
In addition to the methods cited above, EC lineages can be differentiated from mouse ES cells by seeding the latter on feeder cell layers or on collagen type IV-or gelatin-coated culture plates. In these culture systems, Flk-1-expressing cells derived from differentiating ES cells reportedly represent common vascular progenitor cells, as they can give rise to vascular cell types, including arterial, venous and capillary, which eventually form a functional vascular network supported by mural cells (pericytes or vascular smooth muscle cells) and basement membrane [75] . At day 4 of ES cell culture, Flk-1-expressing cells are re-plated with medium supplemented with VEGFs to promote EC differentiation [76] . After 4 more days, cells express VE-cadherin+ and can be isolated using flow cytometry [76] . Cells are maintained in EGM-2 medium on fibronectin-coated plates for 1 to 2 passages [76] . When ECs are placed in a 3D-type 1 collagen matrix in the presence of phorbol myristate acetate (PMA), VEGF165 or bFGF, they differentiate into capillary-like tubular networks [77] .
Foxo1, a member of the Foxo subfamily of forkhead box transcription factors, regulates EC morphology in mouse in response to VEGF 165 [78] . To assess Foxo1 function in ECs, Foxo1(+/+) and (−/−) ES cells were cultured on OP9 feeder cell layers [78] . After 4 days Flk-1+/E-cadherin+ cells were isolated and allowed to form aggregates in the presence of VEGF-A. When grown on type I collagen gel, Foxo1(+/+) vascular progenitors formed long capillary-like structures, whereas Foxo1(−/−) cells formed short sprouts with irregular shape (Fig. 4) , suggesting that Foxo1 deficiency perturbs the EC microtubular system [78] .
Induction of ECs from Non-Human Primate ES Cells
Monkey ES cells are morphologically more similar to human ES cells than are mouse cells. Monkey ES (R278.5) cells are derived from rhesus monkey blastocysts and exhibit cell surface markers that differ from mouse ES cells [79] . For example, undifferentiated monkey ES cells express VEGFR-2 [80] . Monkey ES cells can be maintained in an undifferentiated state in the absence of LIF and have a longer doubling time than do mouse ES cells [79] . When cultured on OP9 feeder layers, they lose VEGFR-2 expression by day 4 and then reacquire it at day 8 [80] . Culture of VEGFR-2+/VE-cadherincells sorted by flow cytometry on the OP9 feeder layers results in their differentiation into ECs expressing CD31, VEcadherin and eNOS (endothelial nitric oxide synthase) after 5 days [80] . VEGFR-2+/VE-cadherin-cells differentiate into SMA+ calponin+ mural cells when cultured on a collagen type IV-coated dish [80] . In the presence of VEGFs, VEGFR-2+/VE-cadherin-cells form CD31+ ECs surrounded by SMA+ mural cells . When these differentiated VEGFR-2+ cells are further cultured in a 3D culture system, capillary-like structures form, indicating that VEGFR-2 is expressed on both undifferentiated monkey ES cells and on EC progenitors differentiated from those cells [80] .
Induction of ECs from Human ES Cells
Like monkey ES cells, undifferentiated human ES cells express VEGFR-2 [81] . They also express AC133, c-Kit and tumor rejection antigen 1-60 (TRA1-60, a marker of human ES cells), but not CD34 [81] . Human HES3 ES cells give rise to colonies of EC precursor and further differentiate into ECs on OP9 feeder layers [81] . Differentiated HES3 cells express VEGFR-2 but not TRA1-60 on day 8 of culture [81] . Isolated VEGFR-2+/TRA1-60-cells do not differentiate efficiently into CD34+ /VE-cadherin+/CD31+/eNOS+ ECs on collagen type IVcoated dishes in the presence of VEGFs and fetal bovine serum without feeder cell layers after 8 days [81] . Following continuous EC culture, CD31+ cells formed capillary-like structures with morphology similar to that of vessel endothelium [81] .
Culture of human ES cells on collagen type IV-coated dishes for 6 days promoted CD31, CD34, AC133, TIE-2 and GATA3 expression, indicative of ECs [82] . After seeding ECs in 3D collagen gels or Matrigel in the presence of VEGF, a capillary-composed of elongated ECs formed within the matrix [71] . Several studies show that cultured ECs derived from human ES cells form capillary tubes when ECs are cultured in Matrigel [71, 81] .
ECs derived from ES cells in vitro reportedly exhibit properties similar to those of arterial-venous-lymphatic ECs [83] . These cells trans-differentiate into smooth muscle cells in vitro and that process is inducible by culture on laminin-1 coated-dishes or in the presence of TGF-β1 [84] . Their smooth muscle phenotype is further supported by expression of both CD31 and α-SMA markers [85] .
EC Differentiation from iPS Cells
Induction of ECs from Mouse iPS Cells
Mouse iPS cells established from fibroblasts form EC precursors expressing Flk-1, when cultured for 5 days on OP9 feeder layers [86] . Those EC precursors also express eNOS, CD31, VE-cadherin and Tie1 [86] . Mouse iPS cells also differentiate into Flk-1+ cells when cultured for 4 to 4.5 days on gelatincoated dishes without LIF [87] . Flk-1+ cells form and are replated on confluent mitomycin-C-treated OP9 feeder layers, eventually giving rise to VE-cadherin+ EC colonies [87] . Colony size and number are enhanced by angiopoietin-1 treatment, which promotes vasculogenesis [87] . Implantation of Flk-1+ cells from mouse iPS cells enhances ischemia-induced angiogenesis in a mouse hind limb model of ischemia: injected Flk-1+ cells derived cells from iPS cells incorporated into the capillary network and promoted angiogenesis in vivo [88] . Flk-1+ cells derived from mouse iPS cells generate mural cells in addition to ECs when cultured on OP9 feeder cell layers, like ES cells [89] . By varying cultivation methods, iPS cells form CD31+/CXCR4+ arterial ECs or lymphatic EC colonies expressing Lyve1+ or Prox1+ [89, 90] .
Induction of ECs from Human iPS Cells
ECs can also be differentiated from human iPS cells [6, 90] . The morphologies and characteristics of three human ES cell lines were compared with four human iPS (201B6, 201B7, 253G1, and 253G4) lines produced from human skin fibroblasts by standard reprogramming techniques [90] . Those human iPS cell lines were differentiated into ECs using a 2D culture system [90] . The EC markers VE-cadherin was detected after 10 days of differentiation, and VE-cadherin+ cells expressed the EC markers FLK-1, CD31 and CD34 [90] . Further culture of CD31+/CD34+ cells in Matrigel in the presence of VEGFs or platelet-derived growth factor (PDGF)-BB formed capillary-like structures [90] . This study shows that human iPS-derived and ES-derived ECs possess similar properties in vivo, as they expressed VE-cadherin, CD31, vWF (von Willebrand factor) and CD34 [90] . In addition, VE-cadherin+ ECs and SMA+ mural cells derived from iPS cells exhibited characteristics identical to human ES cell-derived cells, among them, Flk-1 expression [90] . Human fetal, neonatal and adult fibroblasts are reprogrammed into human iPS cell lines with POU5F1, SOX2, NANOG and LIN28 and can be maintained in an undifferentiated state by culture with MEFs [6, 91] . To induce human iPS cell lines towards EC development, human iPS cell lines can be cultured on OP9 feeder cell layers for 8 days without cytokines. ECs (CD31+/CD34+/CD43-) are detected and further cultured on fibronectin-coated plastic dishes supplemented with endothelium serum-free medium in the presence of bFGF, acidic FGF and heparin [6] . Cultured ECs form a single layer and express VE-cadherin, vWF, VEGFR-2, CD31, CD49d and CD105 [6] . Capillary-like structures form when ECs are seeded on growth factor-reduced Matrigel in the presence of endothelial serumfree medium supplemented with VEGFs [6] . These analyses indicate no morphological differences between ECs derived from human ES and iPS cells, and both cell types show identical gene expression patterns [6, 91] .
Indian Hedgehog (IHH) and BMP-4 Signaling During EC Differentiation
In vitro differentiation of nullizygous ES cells is used as an alternative to the analysis of knock-out mouse embryos. A mouse ES cell line nullizygous for the Indian hedgehog gene, Ihh(−/−) was employed to examine the role of Ihh during angiogenesis in vitro. Ihh(−/−) ES cell-derived EBs failed to form blood islands and exhibited reduced differentiation of CD31+ ECs, while Ihh(−/−) embryos formed blood vessels and revealed fewer numbers of ECs in yolk sac [92] . EBs that were derived from ES cells deficient for Smoothend also resembled the phenotype of Ihh(−/−) EBs, suggesting that IHH signaling is required during early angiogenesis [92] .
Addition of recombinant Ihh in the co-culture of human ES cells on OP9 feeder layers promoted differentiation of CD31+ VE-cadherin+ ECs [93] . Inhibition of BMP-4 signaling by neutralizing antibody suppressed the Ihh-induced EC differentiation, while recombinant BMP-4 rescued EC differentiation by cyclopamine (hedgehog inhibitor) [93] . Therefore, hedgehog facilitates EC differentiation via BMP-4 signaling. BMP-4 is known to promote vasculogenesis in EB formation [93] . Hence, addition of BMP-4 in an EB formation culture of human ES cells increased formation and outgrowth of KDR/VEGFR2+ capillary-like network structures [94] . Recently, soluble recombinant endoglin (Eng), an auxiliary receptor of TGF-β family, was shown to enhance BMP-4-induced EC differentiation in a culture of mouse ES cells on gelatin-coated plates [95] . This in vitro result is consistent with the defects of angiogenesis and cardiovascular development found in the Eng-deficient mouse embryos [96, 97] .
Arterialization of ES Cell-Derived ECs
As shown in the case of vasculogenesis and angiogenesis in the mouse embryos, VEGF is a key regulator of EC differentiation from ES cells. When Flk1/VEGFR2+ mesodermal cells derived from mouse ES cells were subcultured to induce EC differentiation on collagen-type IV coated dishes in the presence of high concentration of VEGF (50 ng/mL), expression of arterial marker genes such as Dll4, Notch4 and Ephrin-B2 were elevated in differentiating ECs [98] . In contrast, the venous marker gene COUP-TFII was upregulated in ECs differentiating in the presence of lower concentration of VEGF. The VEGF-dependent arterialization was blocked by γ-secretase, a multi-subunit protease complex involved in the processing of Notch, ErbB4, E-cadherin, Ephrin-B2 and CD44, implying involvement of Notch signaling in this process [98] . Addition of 8bromo-cAMP or adrenomedullin with VEGF further enhanced the differentiation of arterial ECs from Flk-1/VEGFR2+ mesodermal cells derived from mouse ES cells [99] . The arterialization induced by VEGF and cAMP was abolished in RPBJκ-deficient ES cells which lack Notch signaling, although the constitutive active Notch1 alone was not enough to induce arterial ECs [99] . Therefore, coordinated signaling of VEGF, cAMP and Notch1 is likely to be necessary for arterial EC differentiation.
ECs reportedly respond to shear stress generated by blood flow by undergoing changes in cell morphology and function as well as gene expression [100] . Exposure of mouse ES cellderived Flk-1/VEGFR2+ mesodermal cells to laminar shear stress in a subculture on collagen-type IV coated coverslips resulted in an increase expression of Ephrin-B2, an arterial EC marker in the differentiating ECs [100] . Addition of either VEGF receptor kinase inhibitor or γ-secretase inhibitor suppressed the shear stress-induced increase in the expression of Ephrin-B2 [100] , also suggesting that VEGF and Notch signaling pathways play an important role in arterial EC specification.
Growth Factors Sufficient for EC Differentiation
One of the advantages of in vitro differentiation of ES cells is that cell differentiation can be induced in serum-free defined conditions, thereby enabling combination of growth factors sufficient for differentiation of a certain cell lineage to be determined. For instance, low concentration of BMP-4 (1 ng/mL) in a serum-free medium was reportedly sufficient for inducing Brachyury+ VEGFR2+ mesodermal cells from mouse ES cells on collagen-type IV coated dishes [101] . The Brachyury+ VEGFR2+ mesodermal cell subset has a high potential to differentiate into ECs, and high dose of activin was shown to antagonize the BMP-4-induced generation of this endothelialcompetent mesoderm subset [101] . On the other hand, recent study showed that combination of canonical Wnt agonist GSK inhibitor (glycogen synthase kinase inhibitor), activin and FGF2 induced VEGFR2+ mesodermal cell differentiation from Fgf5+ epiblast-stage cells that were initially induced from mouse ES cells [102] . The VEGFR2+ mesodermal cells were further induced to CD31+ AcLDL+ ECs in the presence of VEGF, cAMP, BMP-4, FGF2 and ALK inhibitor [102] . The reason for the discrepancy in the combination of factors which induced mesodermal cell differentiation is not fully understood. Differences of serum-free media and extracellular matrices as well as the timing of growth factor addition may influence the fate of differentiating ES cells. Furthermore, above studies did not even describe the minimum requirement of growth factors for EC differentiation from ES cells. Indeed, BMP-4 and VEGF in a serum-free medium are sufficient to induce CD31+VE-cadherin+ ECs from mouse ES cells on collagen-type IV coated dishes (M.O., unpublished observation), although involvement of endogenous factor(s) secreted from differentiating ES cells (including ECs themselves) cannot be excluded.
Lymphatic Specification of ES Cell-Derived ECs
Another advantage of in vitro differentiation of ES cells is that cell fate can be manipulated by regulating expression of transcription factors. Regulation of the lymphatic marker Prox1 expression by Sox18 was tested by using forced expression of wild-type Sox18 or dominant-negative Sox18RaOp in the EB formation of mouse ES cells [51] . Expression of Prox1 and podoplanin was increased through over-expression of wildtype Sox18, while Sox18RaOp inhibited induction of the lymphatic markers [51] . Neither of the treatments affected vascular EC differentiation as monitored by the expression of Vegfr2, Tie2 and VE-cadherin [51] , suggesting that Sox18 regulates Prox1 expression in an endothelial-specific manner.
In order to identify the target genes of Prox1, a mouse ES cell line in which forced expression of Prox1 is induced by a tetracycline-regulatable gene expression system was employed [103] . Gene expression profiles of Prox1-induced ECs differentiated from ES cells revealed that FoxC2, angiopoietin-2 and HoxD8 are the candidate targets of Prox1. Further investigations showed that HoxD8 up-regulated Prox1 expression in ECs, suggesting a positive-feedback-loop mechanism in which Prox1 expression is maintained by HoxD8 after maturation of lymphatic vessels where Sox18 expression ceases [103] . Taken together with these in vitro data, Sox18-Prox1-HoxD8 axis is likely to play a pivotal role in the regulation of lymphangiogenesis during embryogenesis.
Future Perspectives
Vasculogenesis and angiogenesis are important processes in formation of a functional vascular network. Formation of that network is driven by diverse biological activities, including EC differentiation, migration, and cell-cell adhesion. Studies indicate that ES/iPS-derived ECs mimic characteristics of ECs in vivo. Therefore, in vitro differentiation of the ES/iPS cells could provide opportunities to further explore the roles of the ECs that can be targeted towards vascular development. In vitro differentiation of ES cell systems provides an in vitro model for current research. Recently, we reported that ECs function as hematopoietic niche cells through stem cell factor production in the aorta and placenta in mid-gestational mouse embryos [104] . In fetal liver, liver sinusoidal endothelial cells express TGF-β1, which up-regulates extra-cellular matrix production in mouse hepatoblasts, and Wnt2 and HGF as mentioned in this review. [42, 105] . This finding suggests that some types of ECs regulate others through cytokine production. Thus, in vitro EC differentiation of ES/iPS cells could allow understanding of crosstalk between ECs and other cells, as well as serve as the basis for future regenerative medicine.
